During the past decade, Saint Louis Rheumatology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Saint Louis Rheumatology" are "Systemic Lupus Erythematosus" (2 trials), "Arthritis" (1 trials), "Autoimmune Diseases" (1 trials), "Connective Tissue Diseases" (1 trials) and "Immune System Diseases" (1 trials). Many other conditions were trialed in "Saint Louis Rheumatology" in a lesser frequency.

Most popular intervention types in "Saint Louis Rheumatology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Atacicept 150 mg" (1 trials), "Atacicept 75 mg" (1 trials), "Brentuximab vedotin" (1 trials) and "Deucravacitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saint Louis Rheumatology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Saint Louis Rheumatology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Saint Louis Rheumatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Louis Rheumatology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".